Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001307736 | SCV001497161 | uncertain significance | Hypertrophic cardiomyopathy | 2020-10-15 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with JPH2-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces proline with arginine at codon 278 of the JPH2 protein (p.Pro278Arg). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and arginine. |
Prevention |
RCV003399084 | SCV004112483 | uncertain significance | JPH2-related disorder | 2023-02-14 | criteria provided, single submitter | clinical testing | The JPH2 c.833C>G variant is predicted to result in the amino acid substitution p.Pro278Arg. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |